CAS 1338247-35-0 appears in our catalog under these names: LIMKi 3, >95% (HPLC), BMS-5/ 99.88% (existing batch purity), LIMKi 3, BMS-5, LIMKi 3. Offered by: TRC, TargetMol, GLPBio, Chemat, Biosynth. Available pack sizes: 10mg, 1mg, 5mg, 2mg, 25mg, 50mg, 100mg, 10mM (in 1ml dmso).
LimKi 3 is a member of the class of pyrazoles that is 1-(2,6-dichlorophenyl)-1H-pyrazole which is substituted by a difluoromethyl group at position 3 and by a 2-(isobutyrylamino)-1,3-thiazol-5-yl group at position 5. It is a a potent cell-permeable inhibitor of LIM kinase 1 and 2. It has a role as a LIM kinase inhibitor. It is a secondary carboxamide, a dichlorobenzene, a member of pyrazoles, an organofluorine compound and a member of 1,3-thiazoles.
Source: ChEBI
| Molecular formula | C17H14Cl2F2N4OS |
|---|---|
| Molecular weight | 431.3 g/mol |
| IUPAC name | N-[5-[1-(2,6-dichlorophenyl)-3-(difluoromethyl)pyrazol-5-yl]-1,3-thiazol-2-yl]-2-methylpropanamide |
| InChIKey | IVUGBSGLHRJSSP-UHFFFAOYSA-N |
| SMILES | CC(C)C(=O)NC1=NC=C(S1)C2=CC(=NN2C3=C(C=CC=C3Cl)Cl)C(F)F |
Computed by PubChem (NCBI)